Credits Available: 4.75 AMA PRA Category 1 Credits

Description: This curriculum is designed to address the operational, clinical, and logistical challenges of integrating bispecific antibody (bsAb) therapies across the RWJBarnabas Health system. Building on established academic protocols, the program guides community clinicians in adapting workflows for safe bsAb administration, clarifying team roles, and strengthening coordination with academic hubs. Through evidence-based modules and practical implementation strategies, participants from each RWJBarnabas Health site will enhance their ability to select and sequence bsAbs appropriately, manage toxicities, and ensure continuity of care and equitable access for patients with multiple myeloma and non-Hodgkin lymphoma.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Hematology/Oncology, Oncology, Pharmacy, Hospitalist, Emergency Medicine, Intensive Care

Sari Jacoby

RWJBH Medical Group: Newark Beth Israel - Cohen Cancer Center
Medical Director

Dr. Sari Jacoby was appointed Medical Director of the Frederick B. Cohen, MD, Comprehensive Cancer and Blood Disorders Center at Newark Beth Israel Medical Center earlier this year. A board certified hematologist/medical oncologist and internist at NBI since 2011, her clinical interests lie in gastrointestinal malignancies and complex blood disorders such as hemophilia and sickle cell disease. She completed her internship, residency, and fellowship at Long Island Jewish Medical Center and her medical degree at Albert Einstein College of Medicine. She is a member of the American Society of Hematology and American Society of Clinical Oncology